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PepFectCell-penetrating peptideswith the ability to escape endosomes and reach the target are of great value as delivery
vectors for different bioactive cargoes and future treatment of human diseases. We have studied two such pep-
tides, NickFect1 and NickFect51, both originated from stearylated transportan10 (PF3). To obtain more insight
into themechanism(s) of peptide delivery and the biophysical properties of an efﬁcient vector system, we inves-
tigated the effect of different bioactive oligonucleotide cargoes on peptide–membrane perturbation and peptide
structural induction. We studied the membrane interactions of the peptides with large unilamellar vesicles and
compared their effects with parent peptides transportan10 and PF3. In addition, cellular uptake and peptide-
mediated oligonucleotide delivery were analyzed. Calcein leakage experiments showed that similar to
transportan10, NickFect51 caused a signiﬁcant degree of membrane leakage, whereas NickFect1, similar to
PF3, was less membrane perturbing. The results are in agreement with previously published results indicating
that NickFect51 is a more efﬁcient endosomal escaper. However, the presence of a large cargo like plasmid
DNA inhibited NickFect's membrane perturbation and cellular uptake efﬁciency of the peptide was reduced.
We conclude that the pathway for cellular uptake of peptide complexes is cargo dependent, whereas the
endosomal escape efﬁcacy depends on peptide hydrophobicity and chemical structure. For small interfering
RNA delivery, NickFect51 appears to be optimal. The biophysical signature shows that the peptide alone causes
membrane perturbation, but the cargo complex does not. These two biophysical characteristics of the peptide
and its cargo complex may be the signature of an efﬁcient delivery vector system.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
The possibility of selectively and efﬁciently manipulating eukaryotic
gene expression holds much promise for modern medicine. Research
has been focused on ﬁnding new stable biomolecules and their synthet-
ic analogs that can correct or substitute disease causing genetic informa-
tion. Among the candidates are nucleic acids, such as double-stranded
plasmid DNA (pDNA) [1,2], short single-stranded splice-correcting oli-
gonucleotides (SCO) [3,4] and small interfering RNA (siRNA) [5,6]., transportan10; NickFect, NF;
C, palmitoyl-2-oleoyl-phospha-
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boxyﬂuorescein
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).Although some recent cases of success can be pointed out [7] the use
of these nucleic acid based therapies in clinical applications is limited
until present by the poor stability in serum containing media and low
uptake into cells due to their high molecular weight, negative charge
and hydrophilic nature.
The use of cell-penetrating peptides (CPPs) as delivery vehicles for
biomolecular cargoes, such as pDNA, SCOs and siRNAs, offers a set of
advantages such as low toxicity and efﬁciency at reduced doses and
some of these peptides are able to promote endosomal escape after
cell internalization [8–10]. Generally, CPPs are deﬁned as short and
water-soluble peptides, which can be hydrophilic (cationic), hydropho-
bic or intermediately hydrophobic [11,12]. A major advantage of some
CPPs is their capacity of forming stable non-covalent complexes with
the cargo [13]. However this strategy often results in entrapment of
the CPP/cargo complexes in endosomal vesicles after cellular uptake
by endocytosis [14–16]. The necessity to improve endosomal escape
has driven the insertion of several chemical modiﬁcations to CPPs,
such as the addition of triﬂuoromethylquinoline moieties or replacing
certain residues with His to make endosomolytic CPPs [6,17–19].
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analog of transportan with the N-terminal fragment from the galanin
neuropeptide and the C-terminal fragment from the wasp venom pep-
tide mastoparan and an extra lysine positioned between the two fused
sequences [20–22]. It belongs to a group of the hydrophobic CPPs with
strong afﬁnity to a model membrane already at low concentrations
[11]. TP10 showed not only high transduction efﬁciency but also high
cell toxicity [23].
Various TP10 analogs have been developed with the objective to in-
crease the bioavailability, stability and efﬁciency in cargo delivery. TP10
was modiﬁed with stearic acid and gave origin to a new family of
stearylated CPPs, named PepFects (PFs). PepFect3 (PF3) is the closest
TP10 analog with only an additional stearyl moiety at the N-terminus,
allowing the formation of stable peptide/oligonucleotide complexes
[4,24]. It has been shown that PF3 has lower afﬁnity for a model
membrane compared to unstearylated TP10 [25]. The other family of
stearylated TP10 analogs is named NickFects. NickFect1 (NF1) resulted
from the replacement of isoleucine8 by a more hydrophilic threonine,
and additionally the insertion of a phosphoryl group to tyrosine3 in
the stearylated TP10 (PF3) sequence. These modiﬁcations increase its
hydrophilicity and reduce its charge leading to a pH-dependent peptide
vector with a good endosomolytic capacity [26–28]. NickFect51 (NF51)
has a kink resulted from two simultaneousmodiﬁcations to PF3, namely
the replacement of lysine7with ornithine and the use of δ-NH2 group of
ornithine7 for subsequent synthesis instead of α-NH2 (Table 1). This
modiﬁcation enhances the stability of the complexes in the cytosol
and their endosomal escape [29–31]. It has been also found that NF51
functions as an efﬁcient CPP in protein production system [27].
The number of CPPs is increasing includingboth protein-derived and
designed peptides with different physico-chemical properties [32].
However, there is still space for improvement regarding the efﬁcacy of
CPPs in the presence of serum as well as to enhance their endosomal
escape and biological activities [33]. In addition, both the cellular inter-
nalization and endosomal escape mechanisms of CPPs are not well un-
derstood. Understanding the molecular mechanisms underlying the
CPP cellular uptake and membrane translocation is a necessary prereq-
uisite to characterize the structural basis for modulation of these
peptides. Although several parameters may simultaneously affect their
biological responses, phospholipid–membrane interaction plays a
major role in their cellular uptake and endosomal escape efﬁciencies
and hence their biological activities.
It should be emphasized that the presence of cargo can alter the
mechanism of internalization as well as endosomal escape efﬁciency.
Cargo characteristics such as size, charge and conjugation methodology
have been shown to inﬂuence the CPP translocation mechanismTable 1
Peptides and the respective cargo complexes investigated in this work together with their phy
CPP PF3 NF1
Sequencea Stearyl-AGYLLGKINLKALAALAKKILb Stearyl
Average hydrophobicityc 0.95 0.35
Positive charge 4 3
Concentration (μM)d 5 8
CPP/pGL3
CRe
MR
(3:1)
(7200:1)
(3:1)
(7200:
CPP/SCO
CR
MR
(2:1)
(10:1)
(1.5:1)
(10:1)
CPP/siRNA
CR
MR
(2:1)
(20:1)
(1.5:1)
(20:1)
a All peptides are N-terminally stearylated (stearyl stands for CH3(CH2)16CO\).
b All peptides have amidated C-terminus and peptides used for cellular uptake experiments
c Average amino acid hydrophobicity was calculated according to [40,44].
d Based on the peptide potency in leakage induction, different peptide concentrations were
e CR and MR refer to charge ratio and molar ratio, respectively.[17,34–38]. However there are few studies concerning the effect of
cargo on CPP–membrane interaction and perturbation. One of these
studies showed that streptavidin protein covalently bound to TP10 sig-
niﬁcantly decreases the amount of leakage caused by the peptide while
smaller cargo has no obvious effect on peptide–membrane perturbation
[39]. In 2002, Fischer et al. [37] evaluated CPPs for the controlled import
of small molecules. They studied the dependence of the CPP driven im-
port efﬁciency for different conjugated ﬂuorophores and for the nature
of cargo. They have reported an independence of the nature of the
ﬂuorophore contrasted by a marked dependence of the peptide cargo
[37]. More recently, Freire et al. [40] developed a novel mathematical
lipid partition model, which allows estimating lipid–water partition
constants of supramolecular CPP–cargo complexes from ﬂuorescence
spectroscopy data. In their work they tested the partition extent of
two membrane active peptides derived from dengue virus capsid pro-
tein (DENV C protein) with potential CPP properties, both free and in
the presence of ssDNA molecular cargo. According to the authors,
deducing carrier properties from studies using free CPPs is limited,
due to the structural and chemical rearrangements revealed when
part of supramolecular complexes [40].
This work aims to investigate the membrane bilayer interaction of
three different TP10 analogs, PF3, NF1 and NF51, in the presence or ab-
sence of a cargo. These TP10 modiﬁed peptides have shown different
biological activities when they are non-covalently attached to cargo
molecules [4,26,27]. An obvious question is what variables could drive
the membrane interaction of CPP and CPP/cargo complexes, enhance
the membrane perturbation and therefore make them more efﬁcient
delivery vectors.
We employed large unilamellar vesicles (LUVs) as a bio-membrane
model system to study the abovementioned peptides. LUVs are a simpli-
ﬁed and relevant membrane mimetic system for studying peptide–
membrane interaction and peptide structure induction in the presence
of the membrane. Both neutral vesicles composed of zwitterionic
POPC and partially negatively charged vesicles composed of POPC/
POPG (7:3) phospholipids were used. Three different spectroscopic
methods were used including ﬂuorescence spectroscopy to investigate
peptide induced membrane leakage, circular dichroism (CD) spectros-
copy to evaluate secondary structure induction and dynamic light scat-
tering (DLS) tomeasure the evolution of size. Surface charge using zeta-
potential was also measured for the pure peptide and peptide/cargo
complexes in water solution. Besides biophysical techniques, we stud-
ied the impact of the cargo on the peptide ability to gain intracellular
access utilizing ﬂuorescence activated cell sorting (FACS) on live cells.
In addition, functional assays were used to evaluate and compare their
potentials in delivery of biomolecules. Altogether, the results maysico-chemical properties.
NF51
-AGY(PO3)LLGKTNLKALAALAKKILb Stearyl-AGYLLG)δ-OINLKALAALAKKILb
0.99
4
2
1)
(3:1)
(7200:1)
(2:1)
(10:1)
(2:1)
(20:1)
were labeled with FAM to ε-NH2 group of additional lysine at the C-terminus.
used for peptide/cargo complex preparation in the leakage and CD experiments.
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leading to the design of an optimized CPP.2. Materials and methods
2.1. Materials
Zwitterionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine
(POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3[phospho-rac-(1-
glycerol)] with a negative head group at neutral pH (POPG) were
purchased from Avanti Polar Lipids (Alabaster, Alabama, USA) and were
used without further puriﬁcation. Calcein, a ﬂuorescein derivative
(C30H26N2O13, 622.5 Da) was obtained from Molecular Probes, The
Netherlands. PD-10 desalting columnswere obtained fromGEHealthcare
(Buckinghamshire, UK). Triton X-100 was purchased from Sigma-
Aldrich. PS-2-OMe SCO (5-CCU CUU ACC UCA GUU ACA-3) was
purchased from RiboTask (Denmark), pGL3 Luciferase Reporter Vector
was purchased from Promega (Sweden) and Luciferase siRNA (Sense
3′-TTU AUG CUG CCA UGC AUG CUA-5′, AntiSense 5′-AUA CGA CGG
UAC GUA CGA UTT-3) was a kind gift from Doctor Glynn Williams at
GSK Medicines Research Center.2.2. Peptide synthesis
Peptides used in this study (Table 1)were chemically synthesized on
an automated peptide synthesizer (Applied Biosystems, USA) using
Rinkamide 4-methylbenzhydrylamine resin (0.452 mmol/g, IRIS Bio-
tech, Germany) to obtain C-terminally amidated peptides using stan-
dard ﬂuorenylmethyloxycarbonyl (Fmoc) solid-phase peptide
synthesis strategy. Reaction was carried out using HOBT/HBTU as cou-
pling reagents in DMF with DIEA as an activator base. For NF51 Boc-L-
Orn(Fmoc)-OH (Bachem, Germany) and for NF1 Fmoc-Tyr(PO3H2)-OH
(Bachem, Germany)were used. Stearylationwas performedbymanual-
ly coupling the stearic acid to the N-terminus of the peptide overnight,
at room temperature with 5 equivalent of stearic acid. For carboxyﬂuo-
rescein (FAM) labeled peptides, 5,6-carboxyﬂuorescein was coupled
on-resin to ε-NH2 group of additional lysine at the C-terminus of pep-
tides. After cleavage (H2O/TIS/TFA 2.5/2.5/95 (v/v)) and precipitation
on cold ether, peptides were puriﬁed by reversed-phase high-
performance liquid chromatography (RP-HPLC), with a C4 preparative
column (250 × 10 mm, Phenomenex Jupiter), running a gradient of
ACN/H2O (0.1% TFA). Puriﬁed peptides were analyzed by MALDI-TOF
MS using alpha-cyano-4-hydroxy-cinnamic acid (α-CHCA) as crystalli-
zation matrix (Voyager-DE STR, Applied Biosystems). MALDI-TOF MS:
NF51: 2434 (calcd: 2434); FAM-NF51: 2921 (calcd: 2921); NF1: 2516
(calcd: 2514); FAM-NF1: 3003 (calcd: 3001); PF3: 2448 (calcd: 2448);
FAM-PF3: 2934 (calcd: 2934).2.3. Preparation of large unilamellar vesicles
Neutral and anionic large unilamellar vesicles were prepared by
dissolving phospholipids (zwitterionic POPC and 30% negatively
charged POPG) at the desired concentration in chloroform to obtain a
homogeneous solution. Then the solvent was removed by evaporating
under high vacuum for at least 3 h. The resulting dried lipid ﬁlm was
re-suspended by addition of 50 mM potassium phosphate buffer solu-
tion (pH 7.4) followed by 10 min of vortexing. Five freeze–thaw cycles
were applied to the solution to reduce the lamellarity. Next,
the lipid solution was pushed through two polycarbonate ﬁlters
(100 nm pore size) 20 times by using an Avanti manual extruder.
This method gave unilamellar vesicles with 100 nm diameter [41].
Dynamic light scattering (DLS) was used to examine the size and stabil-
ity of the vesicles.2.4. Calcein release from large unilamellar vesicles
Large unilamellar vesicles (LUVs) with entrapped ﬂuorophore and
calcein were prepared by using 50 mM potassium phosphate buffer
solution containing 55 mM calcein with the previously mentioned
method. The ﬁnal pH was adjusted to 7.4. Free calcein outside the
vesicles was removed by passing through Sephadex-G25 columns two
times. The ﬂuorescence intensity of calcein with different CPPs was re-
corded on a Horiba Jobin Yvon Fluorolog-3 spectroﬂuorometer using
490 nm excitation and 517 nm emission wavelengths at 20 °C. The
ﬂuorescence intensity in the presence of 55 mM calcein is low due to
self-quenching, but increases upon dilution. The release of calcein was
monitored as an increase in the ﬂuorescence intensity at various pep-
tide incubation time points. The vesicle solution was treated with 10%
(w/v) Triton X-100 to induce 100% calcein leakage. Using this as a refer-
ence and by subtracting the background ﬂuorescence, the degree of
calcein leakage induced by different peptides was calculated using the
following equation: % calcein leakage = [(F− F0) / (Fr− F0)] × 100,
where F0 and Fr are the initial ﬂuorescence intensities observedwithout
peptide and after treatment with Triton X-100, respectively. F is
the ﬂuorescence intensity in the presence of CPPs (or CPP/cargo
complexes). The standard deviation in the endpoints (10 min) was
less than ±10 in units of % calcein leakage.
2.5. Preparation of CPP/cargo complexes
To prepare CPP/cargo complexes, cargo was mixed with the CPP in
water by repeated pipetting and incubated at room temperature for
30 min. The charge ratio (CR) of the CPP to the pGL3 was calculated
taking into account the positive charges of the CPP and negative charges
of pGL3. Complexes with SCO and siRNA in water were prepared with
different molar ratios (MR) corresponding to the amount of moles of
the CPP and the cargo (Table 1). The ratio between the peptide and
cargo was based on previously published data where the efﬁciency of
in vitro transfection was shown to be optimal [4,26,27].
2.6. Zeta-potential measurements
Surface charges of the complexes (zeta-potentials) were measured
in water using a Malvern Zetasizer Nano (ZS) instrument. CPP/cargo
complexes were prepared as described in the previous section. Each
solution was temperature-equilibrated to 20 °C for 1 min in a zeta cell.
2.7. Dynamic light scattering (DLS)
DLS was used to determine the hydrodynamic radius of the vesicles
in the presence and absence of CPPs (or CPP/cargo complexes).
Measurements were carried out using a light scattering instrument
ALV/CGS-3 equipped with a Light Scattering Electronics and Multiple
Tau Digital correlator ALV/LSE-5004. Correlation data were acquired
typically for 3 runs each for 30 s. Correlation functions at 150° were re-
corded at a temperature of 20 °C using a Julabo temperature control.
Data analysis was performed using a nonlinear ﬁt model via ALV-
regularized Fit from the AVL Correlator Software for Windows, version
3.0 (ALVGmbH, Langen, Germany). ALV-NonLinData Analysisﬁts an in-
tegral typemodel function to the correlation function using the CONTIN
2DP constrained regularizationmethod [42,43]. Unweighted (intensity-
weighted) particle size distributions were obtained by ﬁtting data with
the CONTIN 2DP routine [42], presented in the ALV data analysis
package.
2.8. Circular dichroism measurements
Circular dichroism (CD)was used to determine the secondary struc-
ture of the CPPs in complex with the cargoes in buffer and also in the
presence of the phospholipid membrane. CD spectra were recorded on
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and 260 nm were recorded, using a bandwidth of 0.5 nm. A quartz cu-
vette with an optical path length of 4 mmwas used, requiring approxi-
mately 1 ml of sample. The temperature was adjusted using a TC 125
temperature control. The background spectra of the vesicle solution
were subtracted from the peptide spectra. Spectra were collected and
averaged over 10 measurements.
2.9. Fluorescence activated cell sorting (FACS) analysis to measure cellular
uptake
5 × 104 of HeLa cells were seeded 24 h prior to experiments onto
24-well plates using Dulbecco's Modiﬁed Eagle Medium (DMEM) sup-
plemented with 0.1 mM non-essential amino acids, 10% fetal bovine
serum, 100 U/ml penicillin and 100 mg/ml streptomycin. Cells were
treated with FAM-CPP or FAM-CPP/cargo complexes for indicated
times. Thereaftermediawas removed, cells were rinsedwith phosphate
buffered saline (PBS) anddetached from the plate using trypsin/EDTA in
PBS for 5 min at 37 °C. Cells were suspended with PBS containing 5%
fetal bovine serum (FBS). Flow cytometry analysis was carried out on
a BD LSRII ﬂow cytometer (BD Biosciences) and the population of viable
cells was determined from a scatter plot: forward scattered light (FSC)
vs. side scattered light (SSC). A minimum of 10,000 events from the
viable cell population per sample were analyzed.
2.10. Biological activity of transfected cargo to measure transfection
efﬁciency
4 × 104 HeLa cells or 5 × 104 HeLa pLuc 705 cells were seeded 24 h
before the experiment into 24-well plates to reach 75% conﬂuence on
the day of transfection. For pDNA transfection HeLa cells and for SCO
transfection HeLa pLuc705 cells were utilized.
To determine siRNA intracellular delivery, HeLa cells were ﬁrst
transfected with BES PX plasmid, containing luc2 gene using Lipofecta-
mine 2000 for 3 h according to themanufacturer's protocol, followed by
replacement of the medium with fresh serum-containing medium to
avoid toxic effects and treated with CPP/siRNA complexes 24 h post-
transfection with luc2 plasmid.
Cells were treated with preformed complexes for 24 h in serum-
containingmedium,washedwith PBS and lysed using 100 μl 0.1% Triton
X-100 in PBS buffer for 30min at 4 °C. Luciferase activity wasmeasured
using Promega's luciferase assay system on a GLOMAX™ 96 microplate
luminometer (Promega, Sweden). Data was normalized to protein con-
tent measured with a DC protein determination kit (Bio-Rad Laborato-
ries, Inc., USA). Lipofectamine 2000 and LF RNAiMax as positive
controls were used according to the manufacturer's protocol.
2.11. Cell viability measurements
Cell viability was analyzed by CytoTox-Glo™ Assay (Promega,
Sweden). 10,000 HeLa cells were seeded into 96-well plates 24 h before
the experiment. Complexes were formed as described or peptide solu-
tion in MQ was made 10× of given concentration. 100 μl of serum-
containingmediumwas added to cells. 24 h after treatment the number
of dead cells and total cells was measured on the GLOMAX™ 96 micro-
plate luminometer. Results are given as % of live cells (viability).
3. Results
In the present work, the phospholipid membrane interactions and
conformational properties of three TP10 derivative peptideswere inves-
tigated (Table 1). In addition, we studied the impact of the presence of
cargo molecules, non-covalently attached to the peptide, on the pep-
tide–membrane interaction,membrane perturbation aswell as the pep-
tide cellular uptake efﬁciency. We have used three types of cargoes,
which are distinct in their size, structure and number of negativecharges. The Fireﬂy Luciferase SCO RNA is single-stranded with 18 base
pairs and 18 negative charges, the Fireﬂy Luciferase siRNA is double-
stranded with 21 base pairs resulting in 42 negative charges and ﬁnally
the pGL3 is a 5256 base pair circular plasmid DNA molecule which is
highly negatively charged. Functional assayswere performed to compare
biological activities of peptides and evaluate their endosomal escape ef-
ﬁciencies. Table 1 summarizes the investigated peptides and the respec-
tive cargo complexes.
In membrane leakage experiments, several peptide treatment
concentrations were used for all investigated CPPs depending on their
potentmembrane interactions. For comparison, we included the parent
peptide, TP10, in leakage and CD experiments. For CPP/cargo complex
preparation, we have chosen a suitable peptide concentration that in-
duces observable while low leakage (less than 50%) for each peptide.
Due to different peptide potencies in leakage induction, the peptide
treatment concentration used for complex preparation was not the
same for the investigated peptides (Table 1). In all experiments, the se-
lected peptide to cargo ratio was based on previously published data
where the efﬁciency of in vitro transfection was shown to be optimal
[4,26,27]. We used an optimal charge ratio (CR3) for the CPP/plasmid
complex and an optimal molar ratio (MR10 and MR20) for CPP/SCO
and CPP/siRNA complexes, respectively (Table 1). In cellular assays,
the same CPP/cargo ratios were used but to avoid cellular toxicity,
cells were treated with lower peptide concentrations. Cell viability
upon treatment with peptide/cargo complexes was measured with
CytoTox-Glo™ assay (Fig. S9A and B).
3.1. Peptide interaction with the model membrane
The membrane perturbing effects of the peptides alone without
cargoeswere investigated using calcein leakage experiments in zwitter-
ionic POPC and 30% negatively charged (POPC/POPG) LUVs. In the ab-
sence of peptides (or peptide/cargo complexes), no leakage of calcein
from the LUVs was observed. The ﬂuorescence intensity in this case
was low and stable due to the self-quenching of concentrated calcein in-
side the LUVs and low permeability of the phospholipid vesicle mem-
brane to the calcein molecules. After the addition of the peptides to
LUVs, the entrapped calcein could be released into the buffer outside
the LUVs as a result of peptide-induced leakage, leading to an increase
in ﬂuorescence intensity. CPPs were added to the calcein-entrapping
LUV solution which either consisted of 100 μM POPC or 100 μM POPC/
POPG (7:3) and the calcein release was recorded at various time points
at 20 °C. In each titration, ﬂuorescence intensity was recorded during
10 min incubation. Fig. 1A shows the time-dependence of calcein leak-
age from 30% negatively charged LUVs induced by NF1 (8 μM). Fluores-
cence was recorded immediately after addition of the peptide followed
by 2min intervals until the signal wasmaintained constant. The proﬁles
were similar for all peptides indicating that the process is a relaxation
towards equilibrium and has a duration of approximately 10 min. This
observation has been discussed in terms of transient pore formation,
which may stabilize the spontaneous leakage [45]. Fig. 1B shows the
percent of leakage induced by TP10 and its derivatives at different
peptide-to-lipid molar ratios with neutral POPC LUVs and (C) with
30% negatively charged POPC/POPG LUVs, after 10 min of incubation
at 20 °C. Based on Fig. 1A, the leakage values shown in Fig. 1B and C
should represent the ﬁnal level at each peptide concentration. A clear
difference between peptides regarding their induction of calcein leak-
age from LUVs was observed for both neutral and partially negatively
charged LUVs. As shown in Fig. 1B and C, we observed a signiﬁcant
calcein release for NF51 at quite low concentrations, comparable with
its parent peptide TP10. However, the membrane perturbation and
the percent of leakage for PF3 and NF1 were weaker and the peptide
concentration had therefore to be increased in order to induce clearly
detectable leakage. Interestingly, lower peptide–membrane perturba-
tion from the treatments was observed for all CPPs examined with
30% negatively charged LUVs compared to neutral POPC LUVs. Table 2
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Fig. 1. A) Time-dependence of calcein release due to addition of 8 μMNF1 to a vesicle so-
lution containing 55mMentrapped calcein inside 100 μMnegatively charged POPC/POPG
(7:3) LUVs at 20 °C. The percent of calcein leakage was measured for 10min immediately
after addition of the peptide, and plotted as a function of time (min). The medium was
50 mM phosphate buffer (pH 7.4). Calcein leakage experiment with TP10 and the three
derivatives, PF3, NF1 and NF51, titrated to a vesicle solution containing 55mM entrapped
calcein inside B) 100 μMzwitterionic POPC LUVs and C) 100 μMnegatively charged POPC/
POPG (7:3) LUVs at 20 °C. The percent of calcein leakage was measured 10 min after
adding different amounts of the peptides, and plotted as a function of total peptide-to-
lipid molar ratio, P/L. The medium was 50 mM phosphate buffer (pH 7.4).
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PF3 (without cargo) and corrected for peptide concentrations.
3.2. Characteristics of peptide/cargo complex: surface charge and size
measurements
To understand the contribution of the surface charges in membrane
perturbation effects of CPPs and CPP/cargo complexes, the surface
charge state of peptides and peptide/cargo complexes were character-
ized using a zeta-potential analyzer. The complex was based on an
oligonucleotide (pGL3, SCO or siRNA) mixed with the peptide at an
optimal peptide concentration (Table 1) in water and co-incubated for
30min. This resulted in spontaneous formation of a non-covalent conju-
gate between the cargo and the peptide [46]. We have measured the
zeta-potential in water that mimics the properties of the complexes be-
fore addition to the vesicle solution. After addition, both buffer solution
and vesicles may affect the surface charge density. Zeta-potentials of
NickFect peptides were previously measured in physiological condi-
tions [26,27]. Table 2 shows the zeta-potential measured for the pep-
tide/cargo molecules in water.
Complexes with zeta-potential values which are higher than
+30 mV or lower than−30 mV are considered stable [47–49]. While
all investigated cargoes have negative zeta-potentials in water (data
not shown), the zeta value of all CPP/pGL3 complexes in water was
positive at a charge ratio of 3. Plasmid together with TP10 formed a
less stable particle with a zeta value of +11.1 ± 3.7 mV compared to
other CPP/pGL3 complexes having a larger value than +30. Similar to
plasmid complexes, the CPP/SCO complexes formed at molar ratios of
10 were largely positively charged. The zeta-potential values of some
CPP/siRNA complexes were dramatically changed at molar ratio 20.
NF1/siRNA and NF51/siRNA complexes had zeta values of −51.8 ±
2.52 and +17.5 ± 1.42 mV, respectively. However, CPP/siRNA
complexes with TP10 and PF3 were largely positively charged at this
molar ratio (Table 2). All free peptides except TP10 showed highly pos-
itive zeta-potentials in water indicating the presence of stable particles
having positive surface charge (data not shown).
DLS was used in order tomeasure the size of the partially negatively
charged vesicles. Effects of NF51, NF1 and PF3 as well as impact of pep-
tide/cargo complexes on the vesicle size and homogeneity were also
investigated. The size of the vesicle was approximately 100 nm in diam-
eter and addition of NF51 slightly increased the vesicle diameter. Both
NF51/SCO and NF51/siRNA complexes increased the size of the vesicles
and resulted in broader peaks. Interestingly, NF51/pGL3 complexes
induced three different populations (Fig. S1–4). Similar effects were
observed for the other investigated peptides (data not shown).
3.3. Interaction of peptide/cargo complex with the model membrane
To determine the impact of incorporation of the cargo molecules
into the CPPs on the interaction with the phospholipid membrane, the
calcein leakage experiment was performed with both uncharged and
partially negatively charged vesicles. The experiments were performed
by addition of the peptide/cargo complex to the calcein-entrapping
LUVs and recording the calcein ﬂuorescence intensity for 10min as pre-
viously done with the peptides alone.
Fig. 2 shows the effect of different cargoes on peptide–membrane
perturbation and leakage with uncharged (A) and 30% negatively
charged (B) LUVs. Similar effects were observed for NF1 and NF51 in
complex with the cargoes. For both peptides, a drastic decrease in the
membrane leakage could be seen when they were in complex with
pGL3 compared to the peptide alone. Indeed, there was relatively
lower effect of SCO on membrane leakage for NF1 and NF51. siRNA
also decreased the amount of leakage and had a stronger reduction
effect on membrane perturbation caused by NF51. Membrane
charge had a small effect on peptide/cargo membrane perturbation for
NickFect peptides. PF3 acted differently in a way that the added cargo
Table 2
Summary of CPP-mediated uptake and peptide interaction with POPC and POPC/POPG (7:3) LUVs, in the absence and presence of the cargo.
CPP TP10 PF3 NF1 NF51
Relative cellular uptake2
After 15 min
Peptide: 0.5 μM
No cargo n.d.1 1 0.9 0.5
CPP/pGL3
CR3
n.d. 0.9 0.03 0.025
CPP/SCO
MR10
n.d. 0.6 0.17 0.78
CPP/siRNA
MR20
n.d. 0.4 0.8 0.99
Relative cellular uptake2
After 30 min
Peptide: 0.5 μM
No cargo n.d. 1 0.97 0.77
CPP/pGL3
CR3
n.d. 0.99 0.05 0.07
CPP/SCO
MR10
n.d. 0.6 0.3 0.7
CPP/siRNA
MR20
n.d. 0.9 0.8 0.95
Relative cellular
uptake2
After 60 min
Peptide: 0.5 μM
No cargo n.d. 1 0.98 0.97
CPP/pGL3
CR3
n.d. 1 0.1 0.2
CPP/SCO
MR10
n.d. 0.95 0.5 0.95
CPP/siRNA
MR20
n.d. 1 0.98 0.97
POPC
Relative membrane perturbation3
No Cargo n.d. 1 0.8 3.5
CPP/pGL3
CR3
n.d. 1.1 0 0
CPP/SCO
MR10
n.d. 1.7 0.5 2.4
CPP/siRNA
MR20
n.d. 0.8 0.2 0
POPC/POPG (7:3)
Relative membrane perturbation3
No Cargo n.d. 1 0.8 3.2
CPP/pGL3
CR3
n.d. 0.9 0 0.3
CPP/SCO
MR10
n.d. 0.8 0.5 1.6
CPP/siRNA
MR20
n.d. 0 0.4 0.1
Zeta-potential
(in water)4
(mV)
CPP/pGL3
CR3
11.1 (3.7) 61.2 (5.1) 35.1 (0.71) 46.5 (1.96)
CPP/SCO
MR10
11.5 (3.81) 45.2 (1.57) 38.1 (1.94) 39.8 (3.32)
CPP/siRNA
MR20
3.65 (1.13) 34.8 (1.69) −51.8 (2.52) 17.5 (1.42)
1 Not determined.
2 The cellular uptake values are normalized to values for PF3 without cargo.
3 For comparison, leakage values are normalized to values for PF3 (without cargo) and corrected for peptide concentrations.
4 For zeta-potential, the value in the parenthesis is standard deviation.
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compared to NickFect peptides. Interestingly, there is almost no effect
of plasmid on PF3–membrane interaction and leakage, independent of
the membrane charge. However, membrane charge altered the effects
of SCO and siRNA on membrane perturbation caused by PF3. With
charged vesicles, siRNA inhibited the leakage caused by PF3 and the
addition of SCO had no clear effect on PF3 membrane leakage. In con-
trast, the effects were opposite with uncharged vesicles (Table 2). As a
control experiment, cargoes alonewere added to the vesicles. In the ab-
sence of peptides, no leakage of calcein from the LUVs was observed
(data not shown).
3.4. Induction of secondary structure by peptide and peptide/cargo complex
TP10 derivative peptides and their possible structure induction in
buffer and in the presence bio-membrane mimicking systems were
studied by CD spectroscopy. The temperature was 20 °C in all measure-
ments. Similar to leakage experiments, the peptide concentration was
chosen in which optimal membrane perturbation could be observed
(Table 1). Both buffer and vesicle solution were used as blank samples
and baseline correction was used for the blank. Fig. 3A and B show the
CD spectra of peptides in the buffer, and in the presence of uncharged
vesicles, respectively. All stearylated peptides adopted an alpha helical
structure in aqueous buffer. Indeed, CD spectroscopy revealed nodominating secondary structure component for TP10 in buffer. In the
100 μM vesicle solution, with either charged or uncharged membrane,
similar helical structures were induced in stearylated peptides, with
slightly higher intensity in negatively charged vesicles (Fig. S5). Howev-
er, TP10 showed different structures with vesicles depending on the
membrane charge. TP10 in vesicle solution containing negatively
charged membrane adopted an alpha helix structure and it is overall
more structured compared to the structure formedwith uncharged ves-
icles. With uncharged vesicles, TP10 showed a structure similar to that
in the buffer. Taking into account the intensity of the peak at 222 nm,
it is clear that the helicity in the stearylated peptides is weaker com-
pared to TP10 with negatively charged LUVs.
We studied the impact of the presence of SCO and plasmid on pep-
tide secondary structure in the presence of vesicles with uncharged
and 30% negatively charged membranes. In order to clearly observe
the inﬂuence of different cargoes, the spectra of the peptide alone and
peptidewith the cargowere plotted in the same graph.With uncharged
LUVs, the CD spectra of PF3/SCO (Fig. 4A) and NF1/SCO (Fig. S6) were
not affected by the presence of SCO. The CD spectra were characterized
by two minima at 208 and 222 nm indicating an alpha helical state.
However, SCO changed the NF51 secondary structure in uncharged
vesicles (Fig. 4B). The CD spectra of peptides were not affected by the
presence of SCO in 30% negatively charged vesicles (data not shown).
Poor structure induction can be seen when plasmid is in complex
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Fig. 2. Calcein leakage due to addition of the peptides in the presence of oligonucleotide
cargoes (SCO, siRNA and pGL3) to a vesicle solution containing 55 mM entrapped calcein
inside A) 100 μM zwitterionic POPC LUVs and B) 100 μM negatively charged POPC/POPG
(7:3) LUVs at 20 °C. The percent of calcein leakage wasmeasured 10min after adding dif-
ferent peptides and peptide/cargo complexes. The mediumwas 50 mM phosphate buffer
(pH 7.4). All peptide/cargo complexeswere preparedusing anoptimal peptide concentra-
tion, i.e. a concentration that results in an observable percentage of calcein leakage (2 μM
for NF51, 5 μM for PF3 and 8 μM for NF1). Ratios between peptide and cargo are based on
previously determined optimal ratios for efﬁcient cellular transfection assays [4,26,27].
The leakage values were normalized to values for PF3 (without cargo) and corrected for
peptide concentrations.
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Fig. 3. CD spectra of TP10 (solid line), PF3 (dots), NF1 (dashed line) and NF51 (stars) in
A) 10 mM potassium phosphate buffer and B) in 100 μM zwitterionic POPC LUVs,
pH 7.4 at 20 °C. Spectra were corrected by subtracting the buffer (or the LUVs) as a
background.
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and S6).
3.5. Cellular uptake efﬁciency of ﬂuorescently labeled peptides
To evaluate the efﬁciency of the peptide internalization, FACS analy-
sis of HeLa cells exposed to FAM-labeled PF3, NF1 and NF51 was per-
formed. The cells were treated for 15, 30 and 60 min with peptides at
different concentrations (0.5–5 μM). Fig. 5 shows the number of the
cells that has taken up the peptides relative to the untreated cells at dif-
ferent concentrations. The FAM-labeled peptides were able to cross the
cellular membrane of HeLa cells as investigated by FACS analysis
(Table 2). The results revealed that the number of cells containing the
peptide depends on the incubation time and the peptide concentration
and that this dependency was more dominant for NF51. The extent of
cellular uptake of NF1 and PF3 was signiﬁcantly higher than that ob-
served for NF51 after 15 min incubation. NF51 at higher concentrations
of 2 and 3.5 μM showed similar high uptake efﬁciency as the other ex-
amined peptides while at 0.5 μM NF51 required more incubation time
to transfect the whole cell population (Fig. 5).
3.6. Effect of cargoes on cellular uptake efﬁciency
To investigate the impact of the cargoes on peptide-cellular uptake
efﬁciency, we carried out experiments where preformed peptide/
cargo complexes were incubated with the cells in the same way as we
did for free peptides. To establish non-covalent complexes of thepeptides with different cargoes, we used the same peptide/cargo ratios
that we have used for leakage experiments (Table 1).
In the presence of cargo molecules, the cellular uptake was changed
for most peptide/cargo complexes depending on the type of the cargo,
type of the peptide and peptide concentration (Fig. 6A and B). PF3/
pGL3 showed to be taken up equally well as the free PF3. However,
the uptake of NF1 and NF51 in complex with pGL3 was dominantly
diminished after 15 min of incubation and this effect was more
pronounced at lower peptide concentrations (Fig. 6A). Increasing con-
centrations of added peptide/cargo complexes restored the uptake efﬁ-
ciency for NF51 nearly to the level of free NF51 uptake. For NF1 even at
higher concentrations only 60% from the uptake level of the free peptide
was achieved with NF1/pGL3 complexes (Fig. 6B).
With siRNA the cellular uptake was decreased for PF3 complex,
while complex formation with siRNA had no impact to NF51 and NF1
cellular internalization (Fig. 6A). Furthermore, for the PF3/siRNA com-
plex, the internalization level reached that of the free peptide at higher
concentrations (Fig. 6B). The complexes of all the peptideswith SCO en-
tered HeLa cells at lower speed and amount than free PF3. At higher
concentrations of the NF51 and PF3 complexes internalization level
reached the level of free PF3, while NF1/SCO complexes reached about
80% of that level (Fig. 6B).
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Fig. 4. Effect of cargoes on the CD spectra of peptides. A) CD spectra of PF3/SCO, MR10
(stars) and PF3/pGL3, CR3 (dashed line) in 100 μM zwitterionic POPC LUVs compared to
CD spectra of PF3 in 100 μM zwitterionic POPC LUVs (dots), B) CD spectra of NF51/SCO,
MR10 (stars) and NF51/pGL3, CR3 in 100 μM zwitterionic POPC LUVs (dashed line) com-
pared to CD spectra of NF51 in 100 μM zwitterionic POPC LUVs (dots). Spectra were re-
corded at 20 °C and they are corrected by subtracting the buffer (or LUVs) as a
background.
m
Fig. 5. Cellular uptake of FAM-labeled PF3, NF1 andNF51 inHeLa cells in serum containing
medium. HeLa cells were incubatedwith increasing concentrations of peptides for 15 min
at 37 °C and transfected cell population was evaluated by FACS analysis. The results were
presented as percentage to live cells.
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Functional assays were also performed to observe biological
responses as well as to evaluate the endosomal escape efﬁciency of
the peptide/cargo complex. We have used three biological activity ex-
periments including a splice-switching assay representing a positive
read-out based on the presence of the SCO in the nucleus and correcting
the aberrant splice site [50], a siRNA down-regulation assay which is
a negative read-out considering the delivery of the siRNA to the
cytoplasm to induce the gene silencing effect [51] and ﬁnally a plasmid
transfection assay based on using a luciferase-encoding plasmid (pGL3)
and measuring the luciferase activity [52].
For pGL3, NF51mediated about 2 fold higher transfection level com-
pared to NF1. Still, gene expression levels achieved both by NF51 and
NF1 exceeded the luciferase level reached with PF3 about 1000 fold
(Fig. S8). In the splice-switching assay NF1 induced the highest amount
of SCO intracellular delivery, reaching 1.5–2 times higher splice correc-
tion levels than NF51 and 3–4 times higher than PF3 (Fig. S7). Themax-
imal gene silencingwas achievedwith NF51/siRNA complexes resulting
in 90% knock-down of luc-gene. NF1/siRNA and PF3/siRNA complexes
mediated target gene down-regulation was less efﬁcient, reaching 60%
and 30% knock-down, respectively (Fig. 7).
4. Discussion
In the presentwork, we have used the calcein leakage experiment to
characterize the membrane perturbation effects of three different CPPs
in the absence and presence of different cargo molecules. They are all
TP10 based N-terminally stearylated peptides and they slightly differ
regarding amino acid residue composition and chemical structure. We
already knew that TP10 is very potent to disturb model membranes
at low concentrations and that its stearylated version, PF3 shows in-
creased amphipathicity and improved insertion but decreased leakage
and hence lowermembrane perturbation capacity into a lipidmonolay-
er composed of zwitterionic lipids [25]. Due to their similar characteris-
tics, TP10 and PF3 were used as control peptides to study two new
stearylated TP10 analogs, NF1 andNF51. In addition,we studied the cel-
lular uptake efﬁciencies of these peptides in the absence and presence of
the cargomolecules and compared their biological activities. Our results
may clarify the mechanistic parameters essential for the endosomal
escape when a cargo is attached to the CPP.
Peptides that perturb the phospholipid membrane or cause mem-
brane leakage are often discussed in terms of a balance between average
hydrophobicity and total positive charges. Comparing stearylated TP10
analogs (Table 1), we observed that they vary in the context of average
hydrophobicity as well as the total positive charge. Interestingly, a clear
difference in calcein release was also observed with both neutral and
partially negatively charged LUVs treated with TP10 modiﬁed peptides
(Fig. 1B and C). The two CPPs, PF3 and NF1, behave similarly, giving
rise to substantial leakage of the vesicle contents, but NF1 which is the
most hydrophilic between the studied peptides, required a higher con-
centration to perturb themembrane and cause calcein to leak out. Addi-
tionally, NF1 has one negatively charged phosphate group that may
decrease its interaction with the membrane due to the electrostatic re-
pulsion. The highest degree of leakage was observed for NF51, themost
hydrophobic peptide, which was potent already at a low concentration
of 2 μM. In a recently published study, NF51 and NF1 showed different
endosomolytic properties and endosomal escapewas themain problem
for NF1 in gene transfection. It is shown that NF51/pGL3 can quickly
redistribute fromearly endosomes to the cytoplasm [28]. Endosomal es-
cape is also relatively limited for PF3 [4].We suggest that peptide hydro-
phobicity as well as peptide chemical structure is the driving force in
membrane perturbation and leakage. Moreover, presence of ornithine
in NF51mayhave an additional effect onmodelmembrane interactions.
Our results indicate a correlation between phospholipidmembrane per-
turbation and endosomal escape efﬁciencies of investigated CPPs. NF51
AB
Fig. 6. Effect of cargoes on cellular uptake efﬁciency of FAM-labeled PF3, NF1 andNF51 in HeLa cells in serum containingmedia. Complexes of FAM-labeled peptides with different cargoes
were preformed at A) 0.5 μMand B) 2 μMpeptide concentrations. Cargo concentration was calculated according to peptide concentration using charge ratio 3 for pGL3, molar ratio 10 for
SCO and molar ratio 20 for siRNA. Transfected cell population was evaluated by FACS analysis 15 min after transfection at 37 °C and presented as percentage to live cells.
Fig. 7. Inhibition of luciferase expression using peptide/siRNA complexes. HeLa cells were
transfected with BES PX plasmid, containing luc2 gene 24 h before treatment with
preformed NF1, NF51 and PF3 complexes with siRNA MR 20 (ﬁnal concentration
100 nM siRNA) in serum containing medium. Luciferase activity was measured 24 h
after transfection. Untreated cells were taken as 100%. Free siRNA was utilized as a nega-
tive control and Lipofectamine 2000 and LF RNA iMAX as positive controls.
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tions is efﬁcient in endosomal escape. Analyzing FACS results showed
that NF51 has about 2-fold lower cellular uptake efﬁciency compared
to NF1 and PF3 (Fig. 5 and Table 2). This observation further suggests
the presence of different mechanisms in peptide cellular internalization
and endosomal escape. NF51 has strong ability to perturb the
endosomal membrane while utilizing a slower internalization mecha-
nism compared to NF1 and PF3. From the treatmentswith partially neg-
atively charged LUVs, a slightly lower peptide membrane perturbation
compared to uncharged LUVs for all CPPs examined (Fig. 1C) can be ob-
served. Negatively charged vesicles might create a strong interaction
with the positively charged peptides, keeping peptides at the vesicle
membrane surface and not allowing them to penetrate more deeply
into the membrane. Alternatively, it is due to the different vesicle–
membrane permeability caused by charged or uncharged phospho-
lipids. We also showed that decreasing the pH outside the LUVs from
7.4 to 5 enhanced the NF1 membrane perturbation and leakage and
this effect was dominant for NF1 compared to the other investigated
peptides (data not shown). A simple explanation is that NF1 has a pH
sensitive group that destabilizes the vesicle membrane in the acidic
environment.
Another interesting question waswhether the CPP follows the same
membrane perturbation efﬁciency when electrostatically attached to a
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behavior in terms of membrane interactions. An almost complete inhi-
bition of leakage was observed for NF1/pGL3 and NF51/pGL3 indepen-
dent of membrane charge (Fig. 2A and B). This can be related to the
formation of stable and large complexes between peptide and pGL3
and once the peptide is captured in the complexes it is not available to
interact efﬁciently with the membrane and induce perturbation. The
stability of NickFect/pGL3 complexes was previously studied through
heparin displacement assay where both peptides showed resistance to
treatment with heparin [28]. Both DLS measurements (Fig. S2) and
zeta-potential values (Table 2) for NF51/pGL3 conﬁrm this hypothesis.
In the case of PF3, the presence of pGL3 had no effect on the degree of
interaction and perturbationwith both uncharged and partially charged
LUVs.
The result suggests that PF3 may condense pDNA differently from
NickFect peptides resulting in different interactions. In agreement
with leakage studies, cellular uptake experiments using FACS showed
that pGL3 has no effect on PF3 uptake however it largely decreases
NickFect cellular uptake efﬁciencies at 0.5 μM after a 15 min treatment
(Fig. 6A). In the pGL3 transfection assay, PF3 shows a smaller enhance-
ment of pGL3 delivery even though the PF3/pGL3 is being rather efﬁ-
ciently internalized. Leakage experiments as performed here may not
completely reﬂect the behavior of the NickFect/pGL3 complexes in the
endosomes, because the complexes may be stable in the buffer used
for the calcein experiments but may partially dissociate in endosomes.
Low pH inside the endosomemay destabilize the complex and produce
more free peptides with more tendencies to leak out from the endo-
some. We should also observe that NF1 is a pH sensitive peptide
containing a functional group with buffering capacity which acts differ-
ently when pH drops inside the endosomes causing more membrane
perturbation. Based on these observations together with high pGL3
transfection efﬁciencies of NickFects (Fig. 7), we may conclude that
the rate limiting step for NickFect/pGL3 cellular transfection is the cellu-
lar internalization and not endosomal escape. Once the complex is in-
side the endosome, free NickFect peptides destabilize the endosomal
membrane and promote the endosomal escape. In contrast, the translo-
cation of the PF3/pGL3 through the endosomal membrane is the rate
limiting step for PF3 bioactivity due to the less membrane disruptive
effect of PF3.
Small effects on the membrane perturbation and leakage were ob-
tained for the peptide/SCO complexes (Fig. 2A and B). The fact that
the SCO cargo is a small molecule might leave the peptides in the com-
plex exposed to the environment, thus they are still able to interactwith
the membrane and cause leakage. The DLS measurement also showed
one population with slightly larger size when SCO complexes interact
with the vesicles (Fig. S3). SCO enhanced the cellular uptake efﬁciency
of NF51. This observation indicates the positive effect of SCO on mem-
brane permeation for NF51, and could possibly facilitate internalization
of NF51 associated SCO molecules by changing the uptake mechanism.
Similar to plasmid transfection assay, NickFects show higher splice-
correcting activity compared to PF3.
In leakage experiments, siRNA shows distinct effects depending on
the peptide andmembrane charge (Fig. 2A and B). With 30% negatively
charged LUVs, siRNA complexes almost completely inhibited the mem-
brane perturbation of PF3 however the effect on NF1 potency was not
that strong (Fig. 2B). In contrast, with uncharged LUVs, complete
leakage inhibition was observed for NickFects in complex with siRNA
(Fig. 2A). These observations suggest that electrostatic interactions
may have an important role in peptide/siRNA membrane interactions
due to the structural characteristics of siRNA complexes.
CD spectra of peptides in buffer (Fig. 3A) clearly show that the
secondary structure of TP10 changes in its derivatives. TP10 adopted
mainly a random coil structure while all stearylated TP10 based pep-
tides showed an alpha helical structure in the buffer. This structural dif-
ference is due to the hydrophobic nature of stearylated N-terminus that
drive the peptide to adopt a helical conformation, possibly by formingmicelle-like particles. Neither secondary structures nor the amount of
membrane leakage of stearylated peptides was strongly dependent on
the choice of vesicle membrane charge.
Secondary structural induction of stearylated peptides in the pres-
ence of vesicles were also investigated when they were in complex
with cargoes, SCO and pGL3 (Fig. 4A and B). The structure changed
only slightly for SCO complexes with PF3 and NF1 in the presence of
LUVs independent of membrane charge. This clearly indicates that the
peptide secondary structure is not affected by the presence of SCO, or
that most peptides are exposed to the vesicle membrane and keep
their conformation. However, the NF51 secondary structure changed
when it was in complex with SCO in the presence of uncharged LUVs.
Results for all investigated peptide/pGL3 complexes were different
showing a relatively weak helical structure with both charged and un-
charged vesicles. This may be explained by an equilibrium between an
unstructured peptide in complexwith the cargo and some free peptides
that are structured. Both CD resultswith SCOandpGL3 are in agreement
with leakage results showing that SCO has less effect on the peptide–
membrane perturbation compared to pGL3. The weaker inﬂuence of
SCO compared to pGL3 on peptide secondary structure as well as leak-
age could be due to differences in the chemical structure of the complex,
possibly combined with a higher presence of free peptides for the SCO
complex.
It should also be observed that NF1 appears to be most efﬁcient for
cargo delivery into the nucleus where SCO has its function, while
NF51 is the most efﬁcient for both cytoplasmic and nucleus delivery
where siRNA and pDNA are functional, respectively. The fact that NF51
changes its secondary structure in complex with SCO (Fig. 4B) may be
related to its less efﬁciency SCO delivery. It also raises the question of
how complex stability contributes to the functionality of the different
complexes.
In summary, the rate-limiting step for NF1 and NF51 in the three
performedbiological assays should therefore be cellularmembrane per-
turbation and internalization. The hydrophobicity of an efﬁcient peptide
should therefore be an important parameter in endosomal membrane
interaction and endosomal escape. However, the electrostatic interac-
tion between the cellular membrane and the peptide/cargo complex
may promote different mechanisms of cellular uptake. Whereas the
proteoglycans would possibly interact with positively charged particles
[53] and negatively charged particles preferentially interact with scav-
enger receptors [54]. Each type of complex could thus have its particular
entry pathway. In this context, it should also be pointed out that our
results do not rule out the participation of a CPP uptake mechanism
involving plasma membrane destabilization.
As shown in Figs. 1 and 2, the biophysical properties of NF51 and its
siRNA complex show that peptide alone causes strong membrane leak-
age while the cargo complex does not induce leakage. In addition, the
complex stability and its capacity to partially dissociate inside the endo-
somemayplay an important role on the biological activity of an efﬁcient
peptide vector. This may be the biophysical signature of an efﬁcient
delivery vector.
5. Conclusions
Our results show that the most hydrophobic peptide, NF51 in this
work, has the highest membrane perturbing effect. Equally important,
the chemical structure of a peptidemay enhance its membrane interac-
tion. While there is no obvious correlation between cellular uptake and
endosomal escape efﬁciencies, results with membrane leakage caused
byNickFects are in good agreementwith the endosomal escape efﬁcien-
cy of the peptide. The present study also indicates different degrees of
membrane leakage and cellular uptake efﬁciency for peptides electro-
statically attached to cargo compared to free peptides. For NickFect pep-
tides, membrane perturbation was reduced in the presence of cargoes
and this effect was much more pronounced for a large cargo like pGL3.
Based on our results, cellular internalization is the rate limiting step
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main conclusions: 1) The peptide and its physico-chemical properties,
mainly its hydrophobicity and chemical structure deﬁne its membrane
perturbation efﬁciency and thus its ability to escape from the
endosomes; 2) peptide complexes have different cellular uptake
efﬁciencies which are cargo type dependent but independent of the
endosomal escape. Our work shows a complete and directed study
addressing the inﬂuence of the most signiﬁcant oligonucleotide thera-
peutic cargo in cell–penetrating peptide interaction with cellular mem-
branes. These ﬁndingsmay also have implication on the development of
newTP10-basedmodiﬁed CPPs thatwill have favorable properties lead-
ing to even more efﬁcient transport vector for intracellular delivery of
nucleic acids and gene therapy.
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